A Clinical Study of TJ004309 With Atezolizumab (TECENTRIQ®) in Patients With Ovarian Cancer and Selected Solid Tumors
I-Mab Biopharma US Limited
I-Mab Biopharma US Limited
M.D. Anderson Cancer Center
British Columbia Cancer Agency
Abramson Cancer Center at Penn Medicine
Catalysis SL
Hoffmann-La Roche
Jules Bordet Institute